Skip to main content

Advertisement

Log in

Big data highlights the association between psoriasis and fibromyalgia: a population-based study

  • Original Article
  • Published:
Immunologic Research Aims and scope Submit manuscript

Abstract

Data on the association between fibromyalgia syndrome (FMS) and psoriasis are scarce. We aimed to examine the association between FMS and psoriasis using a large-scale observational population-based study. This cross-sectional study analyzed data from a big computerized database to evaluate potential differences in the prevalence of psoriasis between patients with FMS and matched control subjects. The study included 18,598 patients with FMS and 36,985 controls. The prevalence of psoriasis was increased in patients with FMS as compared with control subjects (6.7% vs. 4.8%, respectively; OR, 1.4; 95% CI, 1.3–1.5; P < 0.001). This association was robust to multivariate analysis adjustment for sex, age, ancestry, socioeconomic status, and healthcare utilization (OR, 1.3; 95% CI, 1.2–1.4; P < 0.001). When compared with patients with only FMS, patients with a dual diagnosis of FMS and psoriasis presented with FMS at a significantly older age, had a higher mean BMI, and a higher frequency of smoking. To conclude, we found a significant association between FMS and psoriasis. More extensive cooperation between dermatologists and rheumatologists is suggested to enable early identification of their co-occurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Marques AP, Santo A d S d E, Berssaneti AA, Matsutani LA, SLK Y. Prevalence of fibromyalgia: literature review update. Rev Bras Reumatol (English Ed). 2017;57(4):356–63.

    Article  Google Scholar 

  2. Clauw DJ. Fibromyalgia: A clinical review. JAMA. 2014;311(15):1547–55.

    Article  PubMed  Google Scholar 

  3. Vincent A, Lahr BD, Wolfe F, Clauw DJ, Whipple MO, Oh TH, et al. Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester epidemiology project. Arthritis Care Res. 2013;65(5):786–92.

    Article  Google Scholar 

  4. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010;62(5):600–10.

    Article  Google Scholar 

  5. Jones GT, Atzeni F, Beasley M, Flüß E, Sarzi-Puttini P, Macfarlane GJ. The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria. Arthritis Rheum. 2015;67(2):568–75.

    Article  Google Scholar 

  6. Arnold LM, Bennett RM, Crofford LJ, Dean LE, Clauw DJ, Goldenberg DL, et al. AAPT diagnostic criteria for fibromyalgia. J Pain. 2019;20(6):611–28.

    Article  PubMed  Google Scholar 

  7. Lichtenstein A, Tiosano S, Amital H. The complexities of fibromyalgia and its comorbidities. Curr Opin Rheumatol. 2018;30(1):94–100.

    Article  PubMed  Google Scholar 

  8. Laniosz V, Wetter DA, Godar DA. Dermatologic manifestations of fibromyalgia. Clin Rheumatol. 2014;33(7):1009–13.

    Article  PubMed  Google Scholar 

  9. Thune PO. The prevalence of fibromyalgia among patients with psoriasis. Acta Derm Venereol. 2005;85(1):33–7.

    Article  PubMed  Google Scholar 

  10. Tesmer LA, Lundy SK, Sarkar S, Fox DA. Th17 cells in human disease. Immunol Rev. 2008;223(1):87–113.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Reich K. The concept of psoriasis as a systemic inflammation: implications for disease management. J Eur Acad Dermatol Venereol. 2012;26(SUPPL. 2):3–11.

    Article  PubMed  Google Scholar 

  12. Jauch JM. Review article. Found Phys. 1970;1(2):183–9.

    Article  Google Scholar 

  13. Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370(9583):263–71.

    Article  CAS  PubMed  Google Scholar 

  14. Husni ME, Mease PJ. Managing comorbid disease in patients with psoriatic arthritis. Curr Rheumatol Rep. 2010;12(4):281–7.

    Article  PubMed  Google Scholar 

  15. Watad A, Bragazzi NL, McGonagle D, et al. Systemic sclerosis is linked to psoriasis and may impact on patients’ survival: a large cohort study. J Clin Med. 2019;8(4):521. https://doi.org/10.3390/jcm8040521.

  16. Al-Mutairi N, Al-Farag S, Al-Mutairi A, Al-Shiltawy M. Comorbidities associated with psoriasis: an experience from the Middle East. J Dermatol. 2010;37(2):146–55.

    Article  PubMed  Google Scholar 

  17. Takeshita J, Grewal S, Langan SM, Mehta NN, Ogdie A, van Voorhees AS, et al. Psoriasis and comorbid diseases part I. Epidermology. J Am Acad Dermatol. 2017;76(3):377–90.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Marchesoni A, Atzeni F, Spadaro A, et al. Identification of the clinical features distinguishing psoriatic arthritis and fibromyalgia. J Rheumatol. 2012;39(4):849–55.

    Article  PubMed  Google Scholar 

  19. Marchesoni A, De Marco G, Merashli M, et al. The problem in differentiation between psoriatic-related polyenthesitis and fibromyalgia. Rheumatology (Oxford). 2018;57(1):32–40.

    Article  Google Scholar 

  20. http://www.clalit-global.co.il/en/about_clalit.html

  21. Rennert G, Peterburg Y. Prevalence of selected chronic diseases in Israel. Isr Med Assoc J. 2001;3(6):404–8.

  22. Watad A, Bragazzi NL, Adawi M, Aljadeff G, Amital H, Comaneshter D, et al. Anxiety disorder among rheumatoid arthritis patients: insights from real-life data. J Affect Disord. 2017;213:30–4.

    Article  PubMed  Google Scholar 

  23. Levy O, Segal R, Maslakov I, Markov A, Tishler M, Amit-Vazina M. The impact of concomitant fibromyalgia on visual analogue scales of pain, fatigue and function in patients with various rheumatic disorders. Clin Exp Rheumatol. 2016;34(2 Suppl 96):S120–4.

    PubMed  Google Scholar 

  24. Kapoor SR, Hider SL, Brownfield A, Mattey DL, Packham JC. Fibromyalgia in patients with rheumatoid arthritis: Driven by depression or joint damage? Clin Exp Rheumatol. 2011;29(6 SUPPL. 69):S88–91.

    CAS  PubMed  Google Scholar 

  25. Öncü J, Başoǧlu F, Kuran B. A comparison of impact of fatigue on cognitive, physical, and psychosocial status in patients with fibromyalgia and rheumatoid arthritis. Rheumatol Int. 2013;33(12):3031–7.

    Article  PubMed  Google Scholar 

  26. Dommasch ED, Li T, Okereke OI, Li Y, Qureshi AA, Cho E. Risk of depression in women with psoriasis: a cohort study. Br J Dermatol. 2015;173(4):975–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Moon HS, Mizara A, McBride SR. Psoriasis and psycho-dermatology. Dermatol Ther (Heidelb). 2013;3(2):117–30. https://doi.org/10.1007/s13555-013-0031-0.

  28. Arnold LM, Crofford LJ, Mease PJ, Burgess SM, Palmer SC, Abetz L, et al. Patient perspectives on the impact of fibromyalgia. Patient Educ Couns. 2008;73(1):114–20.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Galek A, Erbslöh-Möller B, Köllner V, Kühn-Becker H, Langhorst J, Petermann F, et al. Mental disorders in patients with fibromyalgia syndrome: screening in centers of different medical specialties. Schmerz. 2013;27(3):296–304.

    Article  CAS  PubMed  Google Scholar 

  30. Gerdes S, Zahl VA, Knopf H, Weichenthal M, Mrowietz U. Comedication related to comorbidities: a study in 1203 hospitalized patients with severe psoriasis. Br J Dermatol. 2008;159(5):1116–23.

    Article  CAS  PubMed  Google Scholar 

  31. Neuvonen PJ, Niemi M, Backman JT. Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance. Clin Pharmacol Ther. 2006;80(6):565–81.

    Article  CAS  PubMed  Google Scholar 

  32. Rivera J, Vallejo MA. Fibromyalgia is associated to receiving chronic medications beyond appropriateness: a cross-sectional study. Rheumatol Int. 2016;36(12):1691–9.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Tamber AL, Bruusgaard D. Self-reported faintness or dizziness — comorbidity and use of medicines. An epidemiological study. Scand J Public Health. 2009;37(6):613–20.

    Article  PubMed  Google Scholar 

  34. Blokh Kerpel A, Tiosano S, Amital D, Comaneshter D, Cohen AD, et al. Association of obesity, smoking and socioeconomics strata with the fibromyalgia syndrome. Harefuah. 2019;158(9):583–6.

    PubMed  Google Scholar 

  35. Phan C, Sigal ML, Lhafa M, Barthélémy H, Maccari F, Estève E, et al. Metabolic comorbidities and hypertension in psoriasis patients in France. Comparisons with French national databases. Ann Dermatol Venereol. 2016;143(4):264–74.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

G.D. was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases [P50 AR 070590 01A1].

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. Kridin.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kridin, K., Vanetik, S., Damiani, G. et al. Big data highlights the association between psoriasis and fibromyalgia: a population-based study. Immunol Res 68, 135–140 (2020). https://doi.org/10.1007/s12026-020-09135-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12026-020-09135-7

Keywords

Navigation